These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16822896)

  • 1. Burning mouth syndrome due to efavirenz therapy.
    Borrás-Blasco J; Belda A; Rosique-Robles JD; Casterá MD; Abad FJ
    Ann Pharmacother; 2006; 40(7-8):1471-2. PubMed ID: 16822896
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypersensitivity syndrome associated with efavirenz therapy.
    Bossi P; Colin D; Bricaire F; Caumes E
    Clin Infect Dis; 2000 Jan; 30(1):227-8. PubMed ID: 10619772
    [No Abstract]   [Full Text] [Related]  

  • 3. Manic syndrome associated with efavirenz overdose.
    Blanch J; Corbella B; García F; Parellada E; Gatell JM
    Clin Infect Dis; 2001 Jul; 33(2):270-1. PubMed ID: 11418896
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropsychiatric effects of efavirenz: delayed onset.
    Dawson S; Woods C
    Int J STD AIDS; 2005 Nov; 16(11):769-70. PubMed ID: 16303077
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemolytic anaemia associated with efavirenz.
    Freercks RJ; Mehta U; Stead DF; Meintjes GA
    AIDS; 2006 May; 20(8):1212-3. PubMed ID: 16691081
    [No Abstract]   [Full Text] [Related]  

  • 6. Retinal toxicity due to Efavirenz.
    Curi AL; Freeman G; Kapembwa M; Pavesio C
    Eye (Lond); 2001 Apr; 15(Pt 2):246-8. PubMed ID: 11339611
    [No Abstract]   [Full Text] [Related]  

  • 7. Efavirenz and retinal toxicity.
    Lewis A; Mitchell S
    Eye (Lond); 2002 Jan; 16(1):107. PubMed ID: 11913879
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV-related neutropaenia exacerbated by efavirenz.
    Healy BJ; Freedman AR
    HIV Med; 2006 Mar; 7(2):129-31. PubMed ID: 16420258
    [No Abstract]   [Full Text] [Related]  

  • 9. Cortisol serum levels and their relationship to certain antiretroviral drugs.
    Collazos J; Ibarra S; Loureiro M
    Scand J Infect Dis; 2004; 36(6-7):480-2. PubMed ID: 15307572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efavirenz].
    Taéron C
    Rev Infirm; 2005 May; (111):37-8. PubMed ID: 15991644
    [No Abstract]   [Full Text] [Related]  

  • 11. Efavirenz-induced psychosis.
    de la Garza CL; Paoletti-Duarte S; García-Martín C; Gutiérrez-Casares JR
    AIDS; 2001 Sep; 15(14):1911-2. PubMed ID: 11579266
    [No Abstract]   [Full Text] [Related]  

  • 12. Switching from protease inhibitors to the non-nuke efavirenz.
    TreatmentUpdate; 2001; 12(12):3. PubMed ID: 11570089
    [No Abstract]   [Full Text] [Related]  

  • 13. Efavirenz-induced catatonia.
    Sabato S; Wesselingh S; Fuller A; Ray J; Mijch A
    AIDS; 2002 Sep; 16(13):1841-2. PubMed ID: 12218403
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of abacavir and efavirenz: new antiretroviral drugs to treat HIV-1 infection.
    Wolbach J; Capoccia K
    Nurse Pract; 1999 Jun; 24(6):81-2, 87-90, 92. PubMed ID: 10431297
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neuro-psychiatric adverse effects associated with efavirenz].
    Ramírez-Duque N; López-Cortés LF
    Enferm Infecc Microbiol Clin; 2006 Jan; 24(1):64-6. PubMed ID: 16537067
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of sudden psychiatric disorders related to efavirenz.
    Peyriere H; Mauboussin JM; Rouanet I; Fabre J; Reynes J; Hillaire-Buys D
    AIDS; 2001 Jul; 15(10):1323-4. PubMed ID: 11426084
    [No Abstract]   [Full Text] [Related]  

  • 17. Efavirenz-induced photoallergic dermatitis in HIV.
    Treudler R; Husak R; Raisova M; Orfanos CE; Tebbe B
    AIDS; 2001 May; 15(8):1085-6. PubMed ID: 11400003
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antiretroviral therapy. NNRTI (non-nucleoside reverse transcriptase inhibitor)].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():14-6. PubMed ID: 10863304
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypersensitivity to efavirenz treated with corticosteroids in a 6-year-old child.
    Foti JL; Piatt JP
    AIDS Patient Care STDS; 2003 Jan; 17(1):1-3. PubMed ID: 12614514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?
    Soriano V; Dona C; Barreiro P; González-Lahoz J
    AIDS; 2000 Jul; 14(11):1672-3. PubMed ID: 10983663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.